Urist Marshall
SEC insider (Form 3/4/5 filer). CIK 0001838139. EVP, Research & Investments at Royalty Pharma plc (RPRX). 28 reported Form 4/5 transactions since Sep 2024; latest on Oct 5, 2026. Located in NEW YORK, NY.
Companies Urist Marshall has filed insider reports for
- Royalty Pharma plc (RPRX): Officer, EVP, Research & Investments
Urist Marshall
CIK: 0001838139
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Royalty Pharma plc
Discretionary Trading P&L
Holdings
Transaction History (28 total)
- Oct 5, 2026RPRX
Royalty Pharma plc
SaleDirect4.1K shares at avg. $57.10$236K - Sep 28, 2026RPRX
Royalty Pharma plc
SaleDirect4.1K shares at avg. $57.88$239K - Aug 7, 2026RPRX
Royalty Pharma plc
GiftIndirectLP interests in RPI US Partners 2019, LP
3K shares- - Aug 5, 2026RPRX
Royalty Pharma plc
AwardDirect8.3K shares- - Jul 1, 2026RPRX
Royalty Pharma plc
SaleDirect9.1K shares at avg. $55.88$508K - Jun 24, 2026RPRX
Royalty Pharma plc
SaleDirect9.1K shares at avg. $55.18$502K - May 20, 2026RPRX
Royalty Pharma plc
SaleDirect13.7K shares at avg. $52.75$722K - May 14, 2026RPRX
Royalty Pharma plc
SaleDirect13.7K shares at avg. $53.06$726K - May 6, 2026RPRX
Royalty Pharma plc
AwardDirect18.2K shares- - Feb 11, 2026RPRX
Royalty Pharma plc
AwardDirect20K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 5, 2026 | RPRX Royalty Pharma plc | Sale | 4,126 | $57.10 | $235,595 | Direct |
| Sep 28, 2026 | RPRX Royalty Pharma plc | Sale | 4,126 | $57.88 | $238,813 | Direct |
| Aug 7, 2026 | RPRX Royalty Pharma plc | Gift LP interests in RPI US Partners 2019, LP | 3,000 | - | - | Indirect |
| Aug 5, 2026 | RPRX Royalty Pharma plc | Award | 8,252 | - | $0 | Direct |
| Jul 1, 2026 | RPRX Royalty Pharma plc | Sale | 9,099 | $55.88 | $508,454 | Direct |
| Jun 24, 2026 | RPRX Royalty Pharma plc | Sale | 9,098 | $55.18 | $502,067 | Direct |
| May 20, 2026 | RPRX Royalty Pharma plc | Sale | 13,684 | $52.75 | $721,838 | Direct |
| May 14, 2026 | RPRX Royalty Pharma plc | Sale | 13,684 | $53.06 | $726,137 | Direct |
| May 6, 2026 | RPRX Royalty Pharma plc | Award | 18,197 | - | $0 | Direct |
| Feb 11, 2026 | RPRX Royalty Pharma plc | Award | 19,970 | - | $0 | Direct |
1-10 of 28 transactions